OpenLegislation

Division 14 Pharmaceutical and Medical ProductsF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. aApplication of EU Member State Laws or the Privacy Shield Principles
  2. bFuture Scientific Research
  3. cWithdrawal from a Clinical Trial
  4. dTransfers for Regulatory and Supervision Purposes
  5. e‘Blinded’ Studies
  6. fProduct Safety and Efficacy Monitoring
  7. gKey-coded Data

Annotations

Textual amendments

F1

Decision revoked (31.12.2020) by The Data Protection, Privacy and Electronic Communications (Amendments etc) (EU Exit) Regulations 2019 (S.I. 2019/419), Sch. 3 para. 1(o); 2020 c. 1, Sch. 5 para. 1(1)